Skip to main content

Advertisement

SpringerLink
Log in

Cyclin D1 Immunoreactivity in Meningiomas

  • Original Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Objective Cyclin D1 is an important nuclear protein required for progression of cells through the G1 phase of the cell cycle. The proliferative potential of meningiomas has been studied using various proliferative markers. However, there have been only few published studies evaluating Cyclin D1 immunoreactivity in meningiomas. Purpose of the study The aim of our study was to analyze the Cyclin D1 expression in meningiomas and correlate it both with proliferation markers Ki67 and PCNA, and with meningiomas of WHO grade. Material and methods We evaluated immunoreactivity for proliferative markers (Cyclin D1, Ki-67, and PCNA) in a consecutive series of 64 meningioma samples obtained from patients who underwent surgical resection because of cerebral or spinal meningiomas. Immunohistochemical staining with Ki-67, PCNA, and Cyclin D1 was performed using the microwave processing procedure and LSAB+ methodology. The number of positive cells for each antibody has been determined and shown in percentage in relation to 1000 counted cells. Results All meningioma samples showed immunostaining for Ki-67, PCNA, and Cyclin D1 antibodies. The Cyclin D1 scores exhibited a close correlation with Ki-67 and PCNA immunostaining (P < 0.01). Some meningiomas (15 cases) showed a combination of nuclear and cytoplasmatic (fine granular) Cyclin D1 immunoreactivity. All proliferative indexes have been in positive correlation with meningioma grade. Conclusion Our comparative study of proliferative markers in meningiomas demonstrated Cyclin D1 as a very useful proliferative marker in meningiomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Abramovich CM, Prayson RA (1998) MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29:1420–1427

    Article  PubMed  CAS  Google Scholar 

  • Alama A, Barbieri B, Spaziante R, Bruzzo C, Dadati P, Dorcaratto A (2007) Significance of cyclin D1 expression in meningiomas. A preliminary study. J Clin Neurosci 14:355–358

    Article  PubMed  CAS  Google Scholar 

  • Alt JR, Gladden AB, Diehl JA (2001) p21cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 277:8517–8523

    Article  PubMed  CAS  Google Scholar 

  • Amatya JV, Takeshima Y, Sugiyama K, Kurisu K, Nishisaka T, Fukuhara T, Inai K (2001) Immunohistochemical study of Ki-67 (MIB-1), p53 Protein, p21WAF1, and p27KIP1 expression in Benign, atypical, and anaplastic meningiomas. Hum Pathol 32(9):970–975

    Article  PubMed  CAS  Google Scholar 

  • Arber N, Gammon MD, Hibshoosh H, Britton JA, Zhang Y, Schonberg JB, Roterdam H, Fabian I, Holt PR, Weinstein B (1999) Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. Hum Pathol 30:1087–1092

    Article  PubMed  CAS  Google Scholar 

  • Clurman BE, Roberts JM (1995) Cell cycle and cancer. J Natl Cancer Inst 87:1499–1501

    Article  PubMed  CAS  Google Scholar 

  • Daidone MG, Costa A, Silvestrini R (2001) Cell proliferation markers in human solid tumors: assessing their impact in clinical oncology. Methods Cell Biol 64:359–384

    Article  PubMed  CAS  Google Scholar 

  • Diehl JA, ChengM, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499–3511

    Article  PubMed  CAS  Google Scholar 

  • Gijtenbeek MMJ, Boots-Sprenger HES, Franke B, Wesseling P, Jeuken WMJ (2005) Cyclin D1 genotype and expression in sporadic hemangioblastomas. J Neurooncol 74:261–266

    Article  PubMed  CAS  Google Scholar 

  • Holland TA, Elder J, McCloud JM, Hall C, Deakin M, Fryer AA et al (2001) Subcellar localization of cyclin D1 protein in colorectal tumours is associated with p21WAF1/CIP1265 expression and correlates with patient survival. Int J Cancer (Pred Oncol) 95:302–306

    Article  CAS  Google Scholar 

  • Hsu DW, Efird JT, Headley-White ET (1998) MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 24:441–452

    Article  PubMed  CAS  Google Scholar 

  • Jaaskelainen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461–469

    Article  PubMed  CAS  Google Scholar 

  • Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140–145

    Article  PubMed  CAS  Google Scholar 

  • Kato JY, Matsuoka M, Strom DK, Sherr CJ (1994) Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol 14(4):2713–2721

    Google Scholar 

  • Korshuno A, Shishkina L, Golanov A (2002) DNA Topoisomerase II-a and Cyclin A. Immunoexpression in meningiomas and its prognostic significance an analysis of 263 cases. Arch Pathol Lab Med 126:1079–1086

    Google Scholar 

  • Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberto N, Albanese V (2000) Correlation between histological grade, MIB-1, p53 and recurrence in 69 completely resected primary intracranial meningiomas. Pathol Res Pract 196:483–488

    PubMed  CAS  Google Scholar 

  • Lebe B, Sağol Ö, Ulukus Ç, Çoker A, Sedat Karademir S, Astarcioglu H, Küpelioğlu A, Astarcioğlu I, Obuz F (2004) The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas. Pathol Res Pract 200:389–396

    Article  PubMed  CAS  Google Scholar 

  • Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas: pathology and genetics of tumours of the nervous system. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. IARC Press, Lyon, pp 176–184

    Google Scholar 

  • Madsen C, Schroeder HD (1997) Ki-67 immunoreactivity in meningiomas. Clin Neuropathol 16:137–142

    PubMed  CAS  Google Scholar 

  • Marks SM, Whitewell HL, Lye RH (1986) Recurrence of meningiomas after operation. Surg Neurol 25:436–440

    Article  PubMed  CAS  Google Scholar 

  • Milenkovic S, Berisavac I, Bojović V, Orlić M, Stanković D, Simić A (2005) Multiple spinal meningiomas with positive PR-case report. Mater Med 21(2):105–109

    Google Scholar 

  • Motokura T, Keyomarsi K, Kronenberg HM, Arnold A (1992) Cloning and characterization of human Cyclin D3, a cDNA closely related in sequence to the PRADI/cyclin D1-proto-oncogene. J Biol Chem 267(28):20412–20415

    PubMed  CAS  Google Scholar 

  • Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I et al (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254

    Article  PubMed  CAS  Google Scholar 

  • Pagano M, Theodoras AM, Tam SW, Draetta GF (1994) Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 8:1627–1639

    Article  PubMed  CAS  Google Scholar 

  • Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53 and flow-cytometry in completely resected primary meningiomas. Cancer 82:2262–2269

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Schauble B, Kleihues P, Ohgaki H (1996) Infrequent altera-tions of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. Int J Cancer 66(3):305–308

    Article  PubMed  CAS  Google Scholar 

  • Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20:187–190

    Article  PubMed  CAS  Google Scholar 

  • Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatr 20:22–39

    Article  PubMed  CAS  Google Scholar 

  • Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, Matter K, Balda SM (2006) Regulation of PCNA and Cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 26(6):2387–2298

    Article  PubMed  CAS  Google Scholar 

  • Takahashi AJ, Ueba T, Hashimoto N, Nakashima Y, Katsuki N (2004) The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas. Surg Neurol 61:149–156

    Article  PubMed  Google Scholar 

  • Takeuchi H, Kubota T, Kabuto M, Kitai R, Nozaki J, Yamashita J (1997) Prediction in recurrence of histologically benign meningiomas: PCNA and Ki-67 immunohistochemical study. Surg Neurol 48:501–506

    Article  PubMed  CAS  Google Scholar 

  • Torp SH, Lindboe CF, Granli US, Moen TM, Nordtomme T (2001) Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas. Clin Neuropathol 20:190–195

    PubMed  CAS  Google Scholar 

  • Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK (2001) Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53 wafl pRb and Ki67. Br J Cancer 84:270–275

    Article  PubMed  CAS  Google Scholar 

  • Xiong Y, Zhang H, Beach D (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505–514

    Article  PubMed  CAS  Google Scholar 

  • Xiong Y, Zhang H, Beach D (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7:1572–1583

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Prof. Dr. Dubravka Cvetkovic-Dozic and Prof. Milica Skender-Gazibara and Prof. Slobodan Dozic for useful suggestions and helpful discussion of the manuscript. We also thank Milan Gajic for the crucial help with statistical analysis of data.

Author information

Authors and Affiliations

  1. Department of Clinical Pathology, Clinical Hospital Centre Zemun, Belgrade, Serbia and Montenegro

    Sanja Milenković

  2. Medical Faculty Foca, University of East Sarajevo, Sarajevo, Bosnia and Herzegovina

    Tatjana Marinkovic

  3. Othorinolaryngology, Clinical Hospital Centre Zemun, Belgrade, Serbia and Montenegro

    Milan B. Jovanovic

  4. Mother and Child Institute “Vukan Cupic”, Belgrade, Serbia and Montenegro

    Slavisa Djuricic

  5. Medical Faculty, Institute of Neurology, Belgrade, Serbia and Montenegro

    Ivana I. Berisavac

  6. Neurosurgery, Clinical Hospital Centre Zemun, Belgrade, Serbia and Montenegro

    Iva Berisavac

Authors
  1. Sanja Milenković
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tatjana Marinkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Milan B. Jovanovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Slavisa Djuricic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ivana I. Berisavac
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Iva Berisavac
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanja Milenković.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milenković, S., Marinkovic, T., Jovanovic, M.B. et al. Cyclin D1 Immunoreactivity in Meningiomas. Cell Mol Neurobiol 28, 907–913 (2008). https://doi.org/10.1007/s10571-008-9278-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-008-9278-x

Keywords

Search

Navigation